This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Use of rasagiline
PDMED_RASAGILINE
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
986 |
4. Check minimum number of events
Min. number of events
3
|
986 |
5. Include endpointsNone |
986 |
6. Filter based on genotype QC (FinnGen only) |
897 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF2
Use of rasagiline
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 897 | 412 | 485 |
| Unadjusted period prevalence (%) | 0.19 | 0.15 | 0.22 |
| Median age at first event (years) | 65.86 | 65.73 | 65.98 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 916
- Matched controls
- 9160
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N04BD01
ATC
selegiline; oral
668.7
307.7
648
33
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
190.3
307.7
183
12
N87
ICPC
Parkinsonism
219.0
307.7
552
63
N04BC05
ATC
pramipexole; oral
47.5
307.7
640
426
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
6414.4
307.7
905
116
G20
ICD-10 Finland
Parkinson disease
9928.0
307.7
910
126
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
1688.2
307.7
887
163
193
Kela drug reimbursment
Rasagiline
8144.5
307.7
719
*
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
518.7
307.7
570
29
N04BC04
ATC
ropinirole; oral
324.7
307.7
431
25
N04BB01
ATC
amantadine; oral
54.4
307.7
194
45
N04BD02
ATC
rasagiline; oral
+∞
307.7
916
5
N04BC09
ATC
rotigotine; transdermal
486.0
234.0
224
6
N06DA03
ATC
rivastigmine; oral, transdermal
12.0
204.0
234
254
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
70.4
194.0
106
17
N03AE01
ATC
clonazepam; systemic
10.5
176.0
222
272
R25.1
ICD-10 Finland
Tremor, unspecified
14.9
174.0
166
134
AAG20
NOMESCO Finland
Stereotactic intracranial implantation of electrodes
256.6
168.4
168
8
N04BX02
ATC
entacapone; oral
453.6
157.4
153
*
N05AH04
ATC
quetiapine; oral
5.9
141.5
355
891
N04AA02
ATC
biperiden; systemic
21.3
137.3
106
56
G25.9
ICD-10 Finland
Extrapyramidal and movement disorder, unspecified
27.1
136.2
95
39
G04BD12
ATC
mirabegron; oral
5.6
133.2
347
895
N04BX04
ATC
opicapone; oral
464.5
125.0
122
*
AEA50
NOMESCO Finland
Adjustment of implanted neurostimulator
208.3
123.9
126
7
XA800
NOMESCO Finland
Neuropsychological investigation
10.0
113.5
140
163
ZXM20
NOMESCO Finland
Intraoperative use of computerised tomography
24.9
111.6
80
35
N19
ICPC
Speech disorder
17.7
100.5
84
52
AA5EN
NOMESCO Finland
Brain reseptor or transprot protein distribution isotope imaging
46.7
96.4
57
13
H02AA02
ATC
fludrocortisone; oral
22.9
81.3
60
28
R4130
NOMESCO Finland
Speech therapy
9.8
77.1
93
104
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
14.4
76.6
71
53
L28
ICPC
Limited function/disability (L)
3.6
73.2
359
1395
AA1AD
NOMESCO Finland
CT of head and brain
3.3
68.7
483
2319
SPAT1215
SPAT
Assessment of need for medical rehabilitation
6.7
64.4
110
184
SPAT1229
SPAT
Assessment of need for aid
4.6
61.7
170
436
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.5
59.5
167
434
R1250
NOMESCO Finland
Evaluation of functional capability
8.1
57.7
81
109
C07AA05
ATC
propranolol; systemic
3.3
56.3
280
1072
I95.1
ICD-10 Finland
Orthostatic hypotension
5.5
54.7
115
234
A28
ICPC
Limited function/disability NOS
3.1
54.0
319
1347
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.9
51.2
178
538
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
6.6
48.4
81
132
R35
ICD-10 Finland
Polyuria
3.9
44.9
147
424
D21
ICPC
Swallowing problem
8.8
43.7
56
67
XF606
NOMESCO Finland
Ortostatic test
14.5
42.7
39
28
N06AX11
ATC
mirtazapine; oral
2.6
42.3
418
2249
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.7
41.8
304
1406
Z2445
NOMESCO Finland
Psychologist
6.4
41.5
71
118
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
4.1
41.5
125
339
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.8
39.7
249
1063
R1260
NOMESCO Finland
Evaluation of communicative skills
8.0
39.0
54
71
SPAT1231
SPAT
Assessment of adjustments needed in living environment
7.3
38.5
58
84
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.5
37.8
394
2145
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.4
37.6
411
2285
R53
ICD-10 Finland
Malaise and fatigue
2.5
36.0
318
1597
F02.39
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
192.5
36.0
37
*
K59.09
ICD-10 Finland
Constipation, unspecified
3.5
33.8
130
415
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.9
33.7
106
295
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.7
33.3
223
975
R47.1
ICD-10 Finland
Dysarthria and anarthria
8.4
33.1
44
55
N04BC06
ATC
cabergoline; oral
50.8
32.8
39
8
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
3.6
32.0
117
361
S01.0
ICD-10 Finland
Open wound of scalp
3.2
31.9
139
479
U04
ICPC
Incontinence urine
3.5
31.6
117
364
N39.4
ICD-10 Finland
Other specified urinary incontinence
3.0
29.5
149
558
SPAT1216
SPAT
Assessment of functional ability
2.4
27.7
230
1105
N28
ICPC
Limited function/disability (N)
6.0
27.5
50
88
R5110, ,
SPAT
2.9
27.4
147
568
A06AD11
ATC
lactulose; oral
2.5
27.3
208
960
N04BC07
ATC
apomorphine; parenteral
+∞
27.2
26
*
YX8AD
NOMESCO Finland
Stereotactic CT examination for dose design of radiotherapy
64.1
27.1
31
5
SPAT1234
SPAT
Support of social functional capacity
3.7
26.8
92
271
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.8
26.0
154
626
N04BC02
ATC
pergolide; oral
267.8
25.8
26
*
N03AX12
ATC
[U] gabapentin; oral
2.4
25.7
219
1061
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.4
25.6
101
326
N05BA04
ATC
oxazepam; oral
2.2
25.6
297
1638
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
5.3
25.0
51
100
G21.9
ICD-10 Finland
Secondary parkinsonism, unspecified
34.4
23.5
30
9
N29
ICPC
Neurological sympt/complt other
5.4
23.4
47
91
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
8.2
23.1
31
39
W19
ICD-10 Finland
Unspecified fall
2.7
23.1
137
556
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.3
22.7
205
1012
AAW01
NOMESCO Finland
Implantation of intracranial stimulation device
+∞
22.0
21
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
6.5
22.0
36
57
Z50.5
ICD-10 Finland
Speech therapy
8.5
21.5
28
34
N06AB10
ATC
escitalopram; oral
2.3
21.4
195
965
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.3
21.1
195
970
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
3.4
20.7
80
254
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
3.1
20.5
94
331
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
20.6
20.5
30
15
XKD06
NOMESCO Finland
Physiologic investigation of micturition
4.0
20.2
59
155
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.3
20.1
169
806
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.8
20.1
113
445
XKD00
NOMESCO Finland
Uroflowmetry
2.1
19.9
226
1219
F02.30
ICD-10 Finland
Dementia in Parkinson's disease without additional symptoms
204.2
19.6
20
*
R4130, ,
SPAT
25.2
19.6
27
11
R60.0
ICD-10 Finland
Localized oedema
2.3
19.2
174
856
G02CB01
ATC
bromocriptine; systemic
7.7
19.2
27
36
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.7
19.1
113
456
M48.0
ICD-10 Finland
Spinal stenosis
2.2
18.8
184
934
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
5.4
18.6
37
71
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
7.6
18.3
26
35
M54.5
ICD-10 Finland
Low back pain
1.9
17.8
368
2426
AA5QN, ,
NOMESCO Finland
+∞
17.8
17
*
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
4.4
17.6
45
107
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
3.8
17.3
53
144
S01.41
ICD-10 Finland
Open wound in the temple-jaw region
6.8
17.1
27
41
N31.8
ICD-10 Finland
Other neuromuscular dysfunction of bladder
16.7
16.6
26
16
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
5.0
16.5
36
75
G04BD11
ATC
fesoterodine; oral
4.0
16.5
48
126
AA1AA
NOMESCO Finland
Head X-ray examination
6.4
16.4
27
43
N30.0
ICD-10 Finland
Acute cystitis
2.1
16.3
178
938
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.1
16.3
195
1064
M41.9
ICD-10 Finland
Scoliosis, unspecified
5.7
16.1
30
54
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
18.9
16.1
24
13
R23
ICPC
Voice symptom/complaint
4.5
16.0
39
89
R4110, ,
SPAT
2.1
15.9
178
948
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.8
15.7
81
304
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
4.1
15.6
43
108
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
5.7
15.6
29
52
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
15.6
193
1065
F0230, G20,
ICD-10 Finland
162.7
15.5
16
*
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
7.1
15.3
23
33
G04BD09
ATC
trospium; oral
4.0
15.2
44
115
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.5
15.0
102
440
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
15.4
14.9
24
16
XKC03
NOMESCO Finland
Water cystometry
3.6
14.7
49
141
S72.0
ICD-10 Finland
Fracture of neck of femur
3.1
14.7
62
208
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.4
14.6
111
503
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
3.6
14.5
48
138
UDQ42
NOMESCO Finland
Endoscopic assessment of swallowing function
19.5
14.3
21
11
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.8
13.7
71
267
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
6.6
13.7
22
34
A04
ICPC
Weakness/tiredness general
2.0
13.6
171
946
S70.0
ICD-10 Finland
Contusion of hip
3.1
13.6
58
196
N04BA07
ATC
foslevodopa and decarboxylase inhibitor; parenteral
142.0
13.5
14
*
G04BD08
ATC
solifenacin; oral
2.4
13.4
93
404
G23.9
ICD-10 Finland
Degenerative disease of basal ganglia, unspecified
18.6
13.4
20
11
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
5.0
13.4
29
60
N30.9
ICD-10 Finland
Cystitis, unspecified
2.6
13.4
78
312
UKC02
NOMESCO Finland
Cystoscopy
1.9
13.3
201
1183
ZXH01
NOMESCO Finland
Procedure performed within operation theatre
40.7
13.2
16
*
K02.1
ICD-10 Finland
Caries of dentine
1.7
13.1
515
3964
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.5
13.1
90
389
R1250, ,
SPAT
3.3
13.0
50
158
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
5.4
12.8
25
47
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.3
12.6
103
482
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.0
12.2
141
754
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.9
12.2
59
214
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.2
12.1
48
155
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
11.9
11.9
21
18
K59.0
ICD-10 Finland
Constipation
2.6
11.9
73
300
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.0
11.8
54
190
N03AX16
ATC
[U] pregabalin
1.8
11.7
242
1559
S20.2
ICD-10 Finland
Contusion of thorax
2.7
11.7
65
254
R33
ICD-10 Finland
Retention of urine
2.2
11.7
108
531
N04BC01
ATC
bromocriptine; oral
65.8
11.6
13
*
J01EA01
ATC
trimethoprim; systemic
1.8
11.6
238
1530
S62.3
ICD-10 Finland
Fracture of other metacarpal bone
3.8
11.5
35
95
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
3.4
11.3
41
125
N02BE01
ATC
paracetamol; systemic, rectal
2.4
11.3
845
7648
R4120, ,
SPAT
4.8
11.2
25
53
WX290
NOMESCO Finland
Other blockage of nerve
1.6
11.2
387
2845
H50.52
ICD-10 Finland
Exophoria
5.3
11.1
22
42
M03BX01
ATC
baclofen; systemic
4.0
11.1
31
79
K03.66
ICD-10 Finland
Tooth plaque
2.3
11.0
90
421
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.4
10.9
40
123
Z3226
NOMESCO Finland
Physiotherapist
1.8
10.8
189
1156
A03FA01
ATC
metoclopramide; systemic, rectal
0.4
10.7
73
1508
F02.34
ICD-10 Finland
Dementia in Parkinson's disease, other additional symptoms of mixed type
60.7
10.6
12
*
Z50.1
ICD-10 Finland
Other physical therapy
2.5
10.6
69
291
WX110
NOMESCO Finland
Infiltration anesthesia
1.7
10.6
644
5398
R44.1
ICD-10 Finland
Visual hallucinations
10.2
10.5
20
20
SPAT1172
SPAT
Guidance concerning hydration
3.7
10.3
32
88
EBA00
NOMESCO Finland
Extraction of tooth
1.6
10.1
338
2449
NF1AA
NOMESCO Finland
Hip X-ray examination
2.0
10.0
117
627
R60.9
ICD-10 Finland
Oedema, unspecified
2.4
9.9
72
320
TKC22
NOMESCO Finland
Catheterisation instruction
3.2
9.9
39
126
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
3.6
9.8
32
91
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.7
9.8
52
198
S01.8
ICD-10 Finland
Open wound of other parts of head
4.1
9.8
27
68
L75
ICPC
Fracture: femur
4.8
9.8
22
47
L17
ICPC
Foot/toe symptom/complaint
1.6
9.7
310
2220
R13
ICD-10 Finland
Dysphagia
2.2
9.6
87
424
L89
ICD-10 Finland
Decubitus ulcer and pressure area
3.6
9.6
31
88
R32
ICD-10 Finland
Unspecified urinary incontinence
3.2
9.5
38
124
M54.4
ICD-10 Finland
Lumbago with sciatica
1.8
9.4
174
1078
IBC97
NOMESCO Finland
Other psychiatric aptitude assessment
101.0
9.4
10
*
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
3.4
9.4
34
104
N86
ICPC
Multiple sclerosis
12.5
9.4
16
13
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
2.7
9.3
49
186
NAG63
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, more than 3 vertebraea
8.8
9.3
19
22
F05.9
ICD-10 Finland
Delirium, unspecified
3.4
9.2
33
100
J01CA08
ATC
pivmecillinam; oral
1.6
9.1
314
2283
S06.0
ICD-10 Finland
Concussion
1.9
9.0
113
620
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
0.2
9.0
17
661
C10AA07
ATC
rosuvastatin; oral
0.6
9.0
180
2679
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.7
9.0
218
1454
JX1LA
NOMESCO Finland
Kinetic X-ray of alimentary tract with pictures
18.8
8.9
13
7
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.8
8.9
145
866
U07
ICPC
Urine symptom/complaint other
2.0
8.8
100
530
XKD03
NOMESCO Finland
Urethral pressure profilometry
3.3
8.7
32
99
K08.3
ICD-10 Finland
Retained dental root
2.1
8.7
90
462
R1420, ,
SPAT
11.7
8.6
15
13
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
3.1
8.5
35
116
Z02.4
ICD-10 Finland
Examination for driving licence
0.6
8.5
171
2550
F02.32
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly hallucinations
90.9
8.4
9
*
M41.4
ICD-10 Finland
Neuromuscular scoliosis
+∞
8.3
8
*
N87
ICD-10 Finland
Dysplasia of cervix uteri
+∞
8.3
8
*
K04.1
ICD-10 Finland
Necrosis of pulp
1.9
8.3
103
564
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
2.4
8.2
57
248
WX402
NOMESCO Finland
General anaesthesia
1.6
8.2
212
1434
T08
ICPC
Weight loss
3.5
8.1
27
78
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.8
8.1
118
679
M79.6
ICD-10 Finland
Pain in limb
1.5
8.1
411
3225
G90.3
ICD-10 Finland
Multi-system degeneration
33.7
8.1
10
*
L84
ICD-10 Finland
Corns and callosities
2.6
7.9
44
172
Y94.0
ICD-10 Finland
Accident at home
3.8
7.9
24
65
L03
ICPC
Low back symptom/complaint
1.6
7.9
268
1929
WX002
NOMESCO Finland
Sedation and analgesia
1.6
7.8
200
1348
SPAT1167
SPAT
Insertion of urinary catheter
2.6
7.8
44
174
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.6
7.8
45
180
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
7.7
265
1910
F0232, G20,
ICD-10 Finland
45.4
7.7
9
*
G23.2
ICD-10 Finland
Multiple system atrophy, parkinsonian type [MSA-P]
45.4
7.7
9
*
N06AX21
ATC
duloxetine; oral
1.8
7.7
111
637
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.6
7.7
246
1745
R41.0
ICD-10 Finland
Disorientation, unspecified
2.7
7.6
41
158
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
3.9
7.6
22
58
R4110
NOMESCO Finland
Physiotherapy
1.5
7.4
272
1986
N99
ICPC
Neurological disease other
3.8
7.4
22
59
SAA02
NOMESCO Finland
Basic examination of mouth
1.5
7.4
545
4574
R1430, ,
SPAT
4.1
7.4
20
50
ZXA10
NOMESCO Finland
Bilateral
1.6
7.4
183
1222
I10
ICD-10 Finland
Essential (primary) hypertension
0.7
7.4
474
5596
N04BX01
ATC
tolcapone; oral
+∞
7.3
7
*
F0234, G20,
ICD-10 Finland
+∞
7.3
7
*
M01AH05
ATC
etoricoxib; oral
1.5
7.3
551
4643
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.4
7.2
51
224
SFA20
NOMESCO Finland
Two-surface restoration
1.5
7.2
487
4009
NFJ54
NOMESCO Finland
Internal fixation of fracture of upper femur with intramedullary nail
3.5
7.2
24
70
F05.8
ICD-10 Finland
Other delirium
6.1
7.1
18
30
K02
ICD-10 Finland
Dental caries
2.1
7.0
63
306
C10AX09
ATC
ezetimibe; oral
0.5
7.0
74
1331
R2110
NOMESCO Finland
Giving the first information
2.3
6.9
53
242
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
3.4
6.9
24
72
S01.9
ICD-10 Finland
Open wound of head, part unspecified
3.4
6.9
24
72
R5130, ,
SPAT
11.0
6.8
12
11
N02AA05
ATC
oxycodone; systemic
1.6
6.8
204
1422
SFA10
NOMESCO Finland
One-surface restoration
1.4
6.8
464
3812
F43.29
ICD-10 Finland
Adaptation disorder UNS
3.7
6.8
21
58
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
2.1
6.7
64
318
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.2
6.7
9
365
G25.0
ICD-10 Finland
Essential tremor
2.7
6.7
36
139
R25.8
ICD-10 Finland
Other and unspecified abnormal involuntary movements
22.7
6.7
9
*
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
6.5
6.7
16
25
AXX01
NOMESCO Finland
Memory assessment
6.5
6.7
16
25
I95.9
ICD-10 Finland
Hypotension, unspecified
3.2
6.6
26
84
SPAT1293
SPAT
Other function in accordance with rehabilitation guidance nomenclature
7.9
6.6
14
18
X59
ICD-10 Finland
Exposure to unspecified factor
1.6
6.6
172
1160
SPAT1139
SPAT
Nutrition survey
2.5
6.6
39
158
Z29
ICPC
Social problem NOS
3.4
6.6
23
69
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
1.9
6.5
78
421
Z43.5
ICD-10 Finland
Attention to cystostomy
6.9
6.5
15
22
U02
ICPC
Urinary frequency/urgency
1.6
6.5
146
949
R55
ICD-10 Finland
Syncope and collapse
1.7
6.5
120
742
S72.1
ICD-10 Finland
Pertrochanteric fracture
2.8
6.4
31
113
SCA02
NOMESCO Finland
Preventive oral health care
2.0
6.4
73
388
130
Kela drug reimbursment
Malignant tumour
0.3
6.4
22
617
N08
ICPC
Abnormal involuntary movements
11.1
6.3
11
10
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
0.2
6.3
5
278
R4190
NOMESCO Finland
Nutritional therapy
2.5
6.3
39
162
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.8
6.3
91
524
N04AA01
ATC
trihexyphenidyl; oral
+∞
6.3
6
*
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
26.9
6.2
8
*
S00.0
ICD-10 Finland
Superficial injury of scalp
2.7
6.2
32
121
R5599
NOMESCO Finland
Other rehabilitation service
2.7
6.2
32
121
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
3.0
6.2
27
93
SPAT1125
SPAT
Stoma care and guidance
3.3
6.2
23
72
PA2AD
NOMESCO Finland
CT angiography of brain
6.3
6.2
15
24
M81.0
ICD-10 Finland
Postmenopausal osteoporosis
2.5
6.2
36
145
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
6.1
399
3229
D64.9
ICD-10 Finland
Anaemia, unspecified
1.7
6.1
116
721
OAB43, ,
SPAT
0.4
6.1
35
784
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
2.6
6.1
34
134
M41.5
ICD-10 Finland
Other secondary scoliosis
12.6
6.1
10
8
C10AA05
ATC
atorvastatin; oral
0.7
6.1
297
3742
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.1
6.1
56
276
M70.6
ICD-10 Finland
Trochanteric bursitis
1.6
6.0
131
844
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
1.7
6.0
107
654
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
48
39
12.93
49.02
2.1
1.3
88.29
116.22
nmol/l
0.40
24
29
460
2988
2.08
25.84
2.8
2.3
290.09
228.15
u/l
0.58
443
2830
729
5713
2.35
24.20
7.1
5.1
3750.00
1407.01
e6/l
—
5
86
414
2699
1.97
21.89
3.7
3.6
0.43
0.45
e6/l
0.09
327
2022
634
4829
2.02
20.76
4.9
7.8
1.21
1.21
mmol/l
0.39
539
4180
437
2950
1.92
20.40
1.9
1.8
18.06
20.30
nmol/l
2.83
393
2461
590
4524
1.85
17.24
5.1
4.2
0.00
0.00
estimate
-0.00
161
960
595
4580
1.85
17.10
5.2
4.2
8.98
3.56
estimate
0.25
166
985
599
4622
1.86
17.06
5.1
4.2
0.00
0.34
estimate
0.52
160
917
441
3106
1.81
16.97
4.0
3.7
155.22
79.87
e6/l
0.25
346
2415
673
5423
1.91
16.30
4.9
5.4
6.33
6.79
mmol/l
12.61
659
5200
214
3418
0.51
16.16
3.2
3.5
7.48
7.45
mmol/l
0.04
175
2857
471
3417
1.78
16.10
4.6
4.4
164.83
119.30
e6/l
0.39
355
2494
558
4310
1.75
14.81
2.5
2.3
84.78
94.45
pmol/l
6.67
376
2296
563
4388
1.73
14.18
4.6
6.9
1.21
1.21
mmol/l
0.38
521
4050
303
1990
1.78
14.12
1.9
1.8
389.28
20087232.13
pmol/l
1.41
254
1613
487
3661
1.71
13.88
5.3
4.2
32.87
64.76
ng/l
1.20
418
2897
268
1712
1.80
13.63
2.0
1.8
1158.53
1196.91
nmol/l
0.30
221
1278
178
1012
1.94
13.01
4.9
3.4
—
—
—
0
0
581
4627
1.70
12.94
10.9
16.7
1.18
1.29
inr
7.95
510
3874
451
3362
1.67
12.94
5.4
4.3
0.00
0.03
estimate
2.81
136
798
231
3436
0.56
12.66
4.1
4.2
5.17
8.62
mg/mmol
1.59
153
2155
103
511
2.14
10.87
1.5
1.5
—
—
—
0
0
329
2343
1.63
10.74
4.9
3.8
0.01
0.04
estimate
0.46
134
748
263
3650
0.61
10.26
1.7
2.0
1.16
1.34
mmol/l
4.80
194
2986
254
1722
1.66
9.94
3.5
3.3
1.37
1.01
e6/l
0.53
148
961
516
4152
1.56
9.62
2.8
3.0
—
—
estimate
—
0
0
350
2590
1.57
9.44
5.2
4.3
0.00
0.01
estimate
0.96
142
882
134
767
1.88
9.43
3.1
3.9
1.22
1.23
mmol/l
0.18
109
664
302
2177
1.58
9.04
3.0
2.8
5.19
4.58
e6/l
0.48
284
1994
470
3749
1.52
8.81
2.9
3.1
120.85
153.70
ug/l
3.53
416
3446
857
7923
2.27
8.80
21.8
19.0
26.56
26.46
mg/l
0.03
765
6685
333
2473
1.54
8.66
2.4
2.3
2.91
2.93
mg/l
0.06
269
2114
249
1738
1.59
8.47
1.9
2.0
—
—
—
0
0
117
680
1.83
7.81
1.7
1.7
—
—
—
0
0
18
45
4.06
6.64
1.4
1.9
—
—
—
0
0
223
1595
1.53
6.60
3.7
3.4
2.52
1.98
e6/l
0.30
116
827
20
55
3.70
6.50
3.0
2.4
—
—
—
0
0
473
3921
1.43
6.48
2.5
2.5
71.76
79.24
nmol/l
8.03
417
3470
83
475
1.82
5.83
4.9
4.0
1.02
1.02
ratio
1.75
77
440
484
4082
1.39
5.72
2.6
2.4
—
—
—
0
0
186
1321
1.51
5.61
1.8
1.9
—
—
—
0
0
46
218
2.17
5.51
4.7
3.5
6.98
7.64
mmol/l
1.39
46
212
499
4252
1.38
5.42
3.8
5.4
35.19
35.06
g/l
0.22
462
3995
289
2264
1.40
5.16
2.4
2.6
—
—
—
0
0
696
6309
1.43
5.00
3.8
4.7
11.26
13.56
mm/h
4.72
646
5856
50
261
1.97
4.68
4.4
3.3
1.53
1.59
mmol/l
0.25
50
254
297
2369
1.38
4.68
3.8
4.4
87.00
86.61
%
0.11
292
2324
170
1229
1.47
4.65
1.9
2.0
—
—
—
0
0
561
4935
1.35
4.64
6.0
10.2
4.21
4.17
e9/l
0.13
481
4286
871
8327
1.94
4.61
25.9
23.1
139.96
139.69
mmol/l
2.90
857
8178
742
7890
0.69
4.53
4.3
5.6
1.44
1.44
mmol/l
0.03
658
7211
871
8339
1.91
4.40
25.8
23.3
3.96
4.00
mmol/l
5.04
856
8177
206
1566
1.41
4.28
1.8
2.7
2.34
2.27
g/l
1.15
176
1454
749
7934
0.69
4.20
4.4
5.7
4.44
4.49
mmol/l
0.79
669
7304
243
1909
1.37
4.13
1.9
1.6
1.76
1.43
mg/l
0.54
200
1514
796
7474
1.50
4.10
5.5
5.5
1.90
2.03
mu/l
1.89
722
6797
25
543
0.45
4.07
2.3
2.1
2.97
3.51
ratio
2.32
19
449
142
1019
1.47
4.02
3.0
3.7
2.87
1.93
mmol/l
2.89
135
878
207
1597
1.38
3.91
2.4
2.0
29.82
29.40
s
0.41
198
1549
41
214
1.96
3.88
2.0
2.7
15.84
16.04
%
0.16
41
208
165
1230
1.42
3.81
3.8
7.6
1.98
0.97
mmol/l
2.73
139
1013
48
821
0.56
3.78
1.5
1.7
1.37
1.59
%
2.56
41
681
712
7581
0.73
3.77
3.7
4.7
1.12
1.30
mmol/l
14.29
626
6855
166
1245
1.41
3.70
3.8
7.6
5.38
5.10
kpa
3.52
160
1203
678
6228
1.34
3.68
4.3
4.3
15.37
15.04
pmol/l
2.79
610
5633
166
1246
1.41
3.68
3.8
7.6
13.09
11.98
kpa
1.63
160
1206
769
8078
0.70
3.64
5.0
6.6
2.59
2.59
mmol/l
0.10
683
7415
876
8450
1.84
3.59
27.3
25.7
71.81
82.03
umol/l
30.27
864
8361
98
671
1.52
3.50
5.8
6.1
25.90
24.39
mmol/l
4.53
93
643
212
1681
1.34
3.33
1.9
2.7
11.79
12.45
umol/l
0.72
185
1569
0
83
0.00
3.13
0.0
1.0
—
—
—
0
0
18
75
2.43
2.98
1.9
1.9
1.36
1.70
u/field
0.12
11
40
31
162
1.95
2.98
2.0
1.8
1.40
1.66
mmol/l
1.75
31
157
740
7776
0.75
2.90
6.2
7.4
39.42
40.11
mmol/mol
1.50
669
7224
376
3270
1.25
2.83
2.7
3.2
976.86
1304.84
ng/l
2.16
326
2847
8
18
4.47
2.80
1.8
2.6
—
—
—
0
0
376
3283
1.25
2.70
2.7
3.7
2.34
2.35
mmol/l
0.50
343
2962
8
19
4.24
2.68
1.8
2.5
—
—
—
0
0
715
6715
1.30
2.68
6.0
9.1
79.88
80.77
u/l
0.27
662
6362
54
347
1.59
2.60
2.0
1.8
—
—
—
0
0
183
1471
1.30
2.58
2.0
2.7
20.93
22.34
%
0.70
159
1375
205
1676
1.29
2.54
2.3
3.3
0.83
0.82
mmol/l
2.17
190
1584
875
8506
1.64
2.52
31.8
28.9
244.91
242.65
e9/l
0.50
857
8327
875
8506
1.64
2.52
31.7
28.8
91.66
91.71
fl
0.12
862
8406
45
279
1.64
2.51
1.3
1.6
—
—
—
0
0
875
8507
1.64
2.50
31.8
28.9
4.33
4.44
e12/l
9.00
850
8295
875
8507
1.64
2.50
32.0
29.5
38.90
40.06
%
7.29
862
8401
875
8508
1.64
2.49
32.1
29.1
130.14
134.19
g/l
13.99
861
8408
66
946
0.67
2.48
1.3
1.3
—
—
—
0
0
83
1140
0.70
2.48
3.1
4.4
3.31
25.22
ug/l
2.24
61
950
9
222
0.40
2.45
1.2
1.2
—
—
—
0
0
20
387
0.51
2.43
1.9
1.8
2.86
3.46
mmol/l
2.09
13
295
238
1997
1.26
2.38
2.7
3.2
2.45
2.46
mmol/l
0.44
217
1806
143
1127
1.32
2.32
4.0
7.8
96.49
95.40
%
3.36
137
1094
334
2924
1.22
2.24
2.4
2.6
57.04
91.23
u/l
0.66
303
2698
56
377
1.52
2.23
2.0
1.9
—
—
—
0
0
52
756
0.67
2.12
1.2
1.5
—
—
—
0
0
118
919
1.33
2.09
1.6
3.2
65.51
66.49
g/l
0.84
102
846
10
235
0.42
2.09
1.2
1.3
—
—
—
0
0
47
318
1.50
1.87
1.2
1.3
—
—
—
0
0
119
944
1.30
1.86
2.0
2.3
182.94
133.77
ug/g
1.10
96
752
207
1759
1.23
1.82
1.3
1.3
1.12
1.51
u/ml
0.35
53
455
526
4885
1.18
1.71
4.2
7.2
10.83
11.84
umol/l
1.88
503
4670
7
25
2.81
1.65
1.3
1.1
—
—
—
0
0
9
186
0.48
1.63
1.1
1.2
—
65.35
—
0
20
677
6447
1.19
1.55
24.9
23.8
13.61
13.81
%
3.81
670
6366
60
443
1.38
1.55
2.2
3.5
4.54
4.44
pmol/l
0.24
54
384
10
201
0.49
1.45
1.2
1.2
—
7.22
—
0
15
6
22
2.74
1.43
1.3
1.1
—
—
—
0
0
230
2019
1.19
1.43
5.1
4.4
1.02
1.02
kg/l
2.42
166
1382
7
149
0.47
1.32
1.1
1.1
—
—
—
0
0
20
318
0.62
1.31
1.3
1.7
0.08
0.34
mg/l
—
7
151
117
1396
0.81
1.29
1.2
1.3
6.78
15.14
u/ml
1.15
44
489
16
92
1.75
1.25
1.3
2.0
—
—
—
0
0
803
7811
1.23
1.25
20.6
18.7
82.70
75.43
ml/min/173m2
27.35
758
7325
6
128
0.47
1.17
1.0
1.0
—
—
—
0
0
39
283
1.39
1.16
1.5
1.6
23.08
20.52
u/ml
—
5
50
222
2476
0.86
1.13
2.0
3.0
309.87
353.63
umol/l
9.01
184
2142
99
824
1.23
1.10
2.7
2.5
1.16
0.54
e6/l
0.62
92
788
87
714
1.24
1.10
1.7
1.7
—
—
—
0
0
12
66
1.83
1.09
1.2
1.1
108.58
101.06
pmol/l
0.17
12
66
6
124
0.48
1.05
3.0
5.4
395.33
356.25
umol/l
—
6
114
12
67
1.80
1.05
1.3
1.2
1.97
2.00
mmol/l
0.10
12
60
36
264
1.38
1.03
2.5
3.5
2.05
1.72
index
0.12
19
148
11
60
1.84
1.03
1.4
1.5
—
—
—
0
0
11
60
1.84
1.03
1.4
1.5
—
—
—
0
0
0
29
0.00
0.98
0.0
1.3
—
9.86
—
0
29
0
30
0.00
0.97
0.0
1.2
—
9.95
—
0
10
851
8362
1.25
0.96
10.2
13.8
15.51
25.55
u/l
123.54
779
8110
127
1104
1.17
0.91
6.6
7.7
—
—
—
0
0
774
7912
0.86
0.89
4.9
5.9
5.93
6.07
mmol/l
2.42
681
7184
84
705
1.21
0.89
3.4
3.8
5.18
5.13
kpa
0.25
79
681
132
1502
0.86
0.88
1.2
1.3
24.43
36.16
iu/ml
1.08
36
480
38
290
1.32
0.87
1.3
1.5
295.03
271.38
ug/g
0.35
24
178
18
262
0.68
0.85
2.6
2.1
98.39
89.85
%
1.26
18
252
57
463
1.25
0.83
1.7
1.9
3.10
1.99
ug/l
0.28
48
414
50
401
1.26
0.81
1.5
4.1
58.97
68.67
mg/l
0.20
38
348
50
401
1.26
0.81
1.5
4.1
25.29
50.56
mg/l
1.90
38
350
18
122
1.48
0.80
1.2
1.6
—
—
—
0
0
0
24
0.00
0.79
0.0
1.6
—
—
—
0
0
0
25
0.00
0.79
0.0
1.4
—
12.48
—
0
25
73
864
0.83
0.79
1.3
1.4
—
—
—
0
0
7
124
0.56
0.78
1.7
1.4
—
—
—
0
0
33
427
0.76
0.78
3.1
3.6
92.73
3606.65
u/ml
0.86
26
363
46
368
1.26
0.77
1.5
3.9
4.57
4.96
ratio
0.05
30
214
9
53
1.70
0.75
1.2
1.2
—
—
—
0
0
9
53
1.70
0.75
1.2
1.2
—
—
—
0
0
32
412
0.77
0.73
2.4
2.8
—
—
—
0
0
49
400
1.24
0.71
1.4
2.9
8.57
10.83
g/l
6.16
38
358
12
77
1.57
0.68
1.2
1.6
—
—
—
0
0
12
77
1.57
0.68
1.2
2.1
—
—
—
0
0
15
215
0.69
0.68
1.2
1.3
—
—
—
0
0
32
249
1.30
0.68
1.6
1.6
—
—
—
0
0
33
258
1.29
0.68
1.4
2.3
123.93
127.81
g/l
0.36
28
207
18
249
0.72
0.67
1.3
1.5
—
—
—
0
0
13
191
0.68
0.67
1.1
1.1
—
3.92
—
0
17
10
155
0.64
0.66
1.2
1.2
0.82
0.91
g/l
—
10
155
32
253
1.27
0.62
1.6
2.9
8.26
7.84
kpa
1.11
32
248
8
50
1.61
0.61
1.0
1.5
81.00
85.26
umol/l
—
8
50
269
2864
0.91
0.60
2.5
3.4
25.19
34.76
u/l
8.14
248
2691
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
24
308
0.77
0.57
1.7
1.6
—
—
—
0
0
108
1202
0.88
0.56
3.9
5.4
35.01
32.46
%
1.67
77
767
8
123
0.65
0.55
9.4
3.7
—
—
—
0
0
69
600
1.16
0.55
3.7
3.7
2.14
1.94
mmol/l
0.17
54
459
6
39
1.54
0.53
1.0
1.2
—
70.00
%
—
0
6
23
291
0.78
0.50
1.1
1.4
—
—
—
0
0
53
455
1.17
0.50
1.5
2.8
6.89
7.41
g/l
2.13
42
415
53
455
1.17
0.50
1.5
2.8
4.17
4.20
g/l
0.07
42
415
53
455
1.17
0.50
1.5
2.8
3.40
3.70
g/l
1.04
42
415
22
171
1.29
0.50
1.0
1.4
—
—
—
0
0
14
190
0.73
0.50
1.4
1.3
—
—
—
0
0
7
45
1.56
0.49
1.1
1.6
70.63
51.31
ug/l
—
7
45
7
45
1.56
0.49
1.3
1.5
—
—
—
0
0
7
45
1.56
0.49
1.3
1.5
—
—
—
0
0
22
172
1.29
0.48
1.2
1.1
—
7.23
—
0
15
47
401
1.18
0.48
1.5
3.1
0.19
1.46
g/l
3.92
31
349
7
47
1.49
0.47
1.1
1.3
—
—
—
0
0
86
772
1.13
0.45
2.3
4.0
74.45
93.96
ng/l
2.26
67
663
20
157
1.28
0.43
1.7
1.3
—
—
—
0
0
22
175
1.26
0.43
1.2
1.4
0.70
0.90
nmol/l
0.74
17
146
10
140
0.71
0.43
1.2
1.2
1.39
1.54
g/l
—
10
140
199
1870
1.08
0.43
4.3
4.3
52.54
348.23
ng/l
7.06
170
1584
5
31
1.62
0.43
1.0
1.1
—
—
—
0
0
49
425
1.16
0.42
1.5
2.9
2.83
2.98
g/l
0.55
38
385
8
56
1.43
0.42
1.5
1.5
—
—
—
0
0
12
87
1.38
0.42
1.7
1.3
—
—
—
0
0
68
605
1.13
0.42
2.2
3.7
25.96
24.28
mmol/l
3.92
68
598
5
32
1.57
0.42
1.8
3.4
9.58
9.95
kpa
—
5
32
5
32
1.57
0.42
1.8
3.4
4.88
4.97
kpa
—
5
32
8
58
1.38
0.41
1.5
1.5
—
—
—
0
0
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
0
17
0.00
0.40
0.0
7.8
—
10.39
—
0
17
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
29
241
1.21
0.40
2.2
1.6
—
—
—
0
0
539
5252
1.06
0.40
3.0
3.5
44.03
55.66
u/l
1.04
493
4872
29
242
1.20
0.39
1.4
1.3
473.83
596.81
mg/l
1.49
29
226
80
725
1.11
0.38
3.4
3.1
76.03
60.32
ml/min/173m2
2.29
34
313
37
429
0.86
0.37
1.2
1.2
72.85
115.07
u/ml
0.46
13
152
9
68
1.33
0.37
1.4
1.5
—
—
—
0
0
28
235
1.20
0.36
1.3
1.1
—
—
—
0
0
28
235
1.20
0.36
1.3
1.1
—
—
—
0
0
104
959
1.10
0.36
2.1
2.3
0.20
0.21
g/l
0.08
95
886
33
282
1.18
0.35
1.8
1.7
—
—
—
0
0
23
277
0.83
0.35
1.7
1.6
—
—
—
0
0
42
367
1.15
0.35
1.7
2.9
25.18
24.88
mmol/l
0.23
42
362
23
190
1.22
0.35
1.3
1.8
4.76
35.46
iu/l
—
8
75
14
178
0.78
0.34
1.1
1.3
—
290.77
—
0
13
6
45
1.34
0.33
1.2
1.2
—
—
—
0
0
13
100
1.30
0.33
1.2
1.2
—
—
—
0
0
6
88
0.68
0.33
1.2
1.0
242.33
314.72
ng/l
—
6
54
6
88
0.68
0.33
1.2
1.0
886.67
634.08
ng/l
—
6
53
6
88
0.68
0.33
1.2
1.0
26.00
42.50
ng/l
—
6
52
378
3664
1.05
0.32
5.3
6.1
2.54
2.86
ug/l
0.36
342
3305
6
47
1.28
0.32
1.2
1.1
—
—
—
0
0
6
47
1.28
0.32
1.3
1.3
151.28
146.36
pmol/l
—
6
47
23
192
1.20
0.32
4.7
3.8
28.31
27.76
mg/l
0.03
16
133
92
850
1.09
0.31
1.6
2.2
375.43
378.14
nmol/l
0.04
86
794
20
168
1.19
0.27
1.5
1.9
5.31
4.60
mmol/24h
0.32
15
148
14
113
1.24
0.26
1.7
1.4
—
—
—
0
0
212
2206
0.95
0.26
3.4
3.5
0.63
0.77
ug/l
3.41
159
1539
12
96
1.25
0.24
2.3
2.9
15.00
11.85
index
—
6
60
6
81
0.74
0.24
1.2
1.1
104.17
95.61
%
—
6
75
5
38
1.32
0.23
1.0
1.2
—
—
—
0
0
7
93
0.75
0.22
1.1
1.6
—
—
—
0
0
7
93
0.75
0.22
1.1
1.6
—
—
—
0
0
7
93
0.75
0.22
1.1
1.6
—
—
—
0
0
5
41
1.22
0.22
1.0
1.4
24.60
30.33
umol/l
—
5
36
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
0
11
0.00
0.21
0.0
2.0
—
100.55
—
0
11
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
8
104
0.77
0.21
1.0
1.1
—
2.23
—
0
11
8
105
0.76
0.21
1.1
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
9.2
—
5.31
—
0
13
21
240
0.87
0.20
3.7
3.5
56.02
1633.86
u/ml
0.87
16
225
6
51
1.18
0.19
1.0
1.1
—
—
—
0
0
14
163
0.86
0.17
1.4
1.5
—
—
—
0
0
5
66
0.76
0.17
1.0
1.1
—
—
—
0
0
5
68
0.73
0.17
1.4
1.7
93.20
105.94
ng/l
—
5
68
17
194
0.87
0.16
1.2
1.4
—
—
—
0
0
17
194
0.87
0.16
1.2
1.4
—
—
—
0
0
59
554
1.07
0.16
2.5
2.6
20.26
19.62
au/ml
—
7
36
8
69
1.16
0.16
1.3
1.5
—
395.71
—
0
7
14
120
1.17
0.16
1.6
1.5
—
—
—
0
0
14
120
1.17
0.16
1.6
1.5
—
—
—
0
0
23
206
1.12
0.16
1.5
1.2
3.00
82.72
e6/l
1.28
17
157
121
1258
0.96
0.16
2.4
4.5
228.87
248.95
u/l
1.05
112
1195
6
77
0.78
0.15
1.2
1.4
—
—
—
0
0
303
2968
1.03
0.15
4.3
4.9
20.39
21.33
%
0.67
176
1566
14
121
1.16
0.15
1.6
1.5
—
—
—
0
0
7
86
0.81
0.14
1.0
1.1
—
—
—
0
0
25
274
0.91
0.14
1.1
1.6
—
—
—
0
0
14
122
1.15
0.13
1.6
1.5
—
—
—
0
0
8
99
0.81
0.13
1.1
1.2
126.62
113.62
%
—
8
90
140
1358
1.04
0.13
2.5
6.1
0.98
1.04
mmol/l
1.86
122
1253
23
210
1.10
0.12
1.5
1.2
3.81
3.82
mmol/l
0.02
23
196
79
823
0.96
0.12
2.8
3.1
172.69
207.97
ng/l
0.52
72
763
18
199
0.90
0.11
1.3
1.5
—
—
—
0
0
90
933
0.96
0.11
3.8
7.4
9.87
10.60
mmol/l
0.43
81
900
14
124
1.13
0.11
1.6
1.5
—
—
—
0
0
14
124
1.13
0.11
1.6
1.5
—
—
—
0
0
26
281
0.92
0.11
1.4
1.6
5253.38
13978.13
e6/l
1.61
13
199
31
332
0.93
0.11
1.0
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
46
1.09
0.09
1.2
1.2
—
—
—
0
0
5
47
1.06
0.09
2.4
1.5
0.60
4.00
u/field
—
5
33
5
48
1.04
0.09
1.2
1.1
—
—
—
0
0
22
204
1.08
0.08
1.3
1.4
—
—
—
0
0
16
175
0.91
0.08
1.1
1.8
—
—
—
0
0
91
884
1.03
0.08
2.7
2.6
7.34
7.31
ug/l
0.01
71
795
30
284
1.06
0.07
1.4
1.4
—
—
—
0
0
7
85
0.82
0.07
1.4
1.4
11.86
13.73
u/l
—
7
78
8
94
0.85
0.06
1.3
1.3
9.37
11.49
u/l
—
8
83
36
344
1.05
0.06
1.4
2.9
0.00
0.01
g/l
0.50
30
307
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
34
355
0.96
0.06
2.2
2.6
0.39
0.37
iu/ml
0.12
22
198
35
337
1.04
0.05
1.4
2.9
0.00
0.00
g/l
-0.00
30
292
11
120
0.92
0.05
1.4
1.5
5.56
6.51
mmol/l
0.60
11
114
90
885
1.02
0.04
2.5
2.5
25.16
42.84
u/l
2.79
76
735
25
260
0.96
0.03
1.2
1.6
—
—
—
0
0
10
107
0.93
0.02
1.8
1.5
—
—
—
0
0
14
133
1.05
0.01
1.1
1.6
—
—
—
0
0
106
1051
1.01
0.01
1.9
2.8
6.88
8.23
umol/l
0.45
87
944
52
527
0.99
0.01
1.2
1.9
1.60
1.56
g/l
0.13
43
466
77
776
0.99
0.00
1.9
2.4
13.76
13.33
nmol/l
0.18
69
688
23
234
0.98
0.00
1.3
1.5
—
—
—
0
0
11
105
1.05
0.00
2.6
2.8
—
—
—
0
0
5
59
0.85
0.00
1.0
1.1
—
—
—
0
0
5
59
0.85
0.00
1.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.2
—
24.40
—
0
5
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
32
320
1.00
-0.00
1.3
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
6.23
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
8.4
—
74.80
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
1745.20
—
0
5
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
6
68
0.88
-0.00
1.0
1.1
—
—
—
0
0
5
56
0.89
-0.00
1.0
1.1
—
—
—
0
0
5
54
0.93
-0.00
1.4
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
4.8
—
—
—
0
0
6
60
1.00
-0.00
2.2
2.9
0.67
0.92
index
—
6
60
0
5
0.00
-0.00
0.0
1.6
—
2.60
—
0
5
5
54
0.93
-0.00
1.4
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: PDMED_RASAGILINE – Use of rasagiline
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).